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a b s t r a c t
Objective: To analyze the impact of various clinical, radiological and perioperative factors
that could inﬂuence the facial nerve intraoperative disruption risk (CNVII-IDR) and its long-
term function (CNVII-LTF) after vestibular schwannoma (VS) surgery.
Material and methods: The study included 212 patients operated on for sporadic VS with no
history of previous treatment for VS or CNVII palsy. The mean size of the tumor was 30 mm.
Gross (210) or near-total (2) resections were carried out using the retrosigmoid (210) or
translabyrinthine (2) approach. Correlation studies and multivariate regression analysis (RA)
were performed.
Results: In correlation studies, the CNVII-IDR was increased by: headaches and cerebellar
ataxia if one of them was the ﬁrst symptom of the tumor (33% and 29%, respectively,
p = 0.008); preoperative hydrocephalus (40% vs. 9%, p = 0.01), tumor size >3 cm (18% vs. 5%,
p < 0.01), tumor volume >10 cm3 (19% vs. 4%, p < 0.01), right-sided location 15% vs. 6%,
p = 0.047), lateral ‘‘park-bench’’ position (19% vs. 5% for supine position, p < 0.01) and the
procedure order (16% for the ﬁrst 106 procedures vs. 6% for the last 106 procedures, p < 0.05).
In RA the tumor volume ( p = 0.012), side of the tumor ( p = 0.028) and patient's position
during surgery ( p = 0.016) independently affected the CNVII-IDR. The following factors
correlated signiﬁcantly with satisfactory CNVII-LTF (HB grades I–III): tumor stage <T4
( p = 0.000), tumor size ≤3 cm ( p = 0.000), tumor volume ≤10 cm3 ( p = 0.001), and left-sided
location ( p = 0.048). Additional factors correlated signiﬁcantly with very good CNVII-LTF (HB
grades I–II): anterior CNVII displacement ( p = 0.044), nimodipine use ( p = 0.016), the absence
of postoperative complications ( p = 0.019), CNVII responsive on ﬁnal intraoperative EMG
stimulation ( p = 0.000) and supine position during surgery ( p = 0.018). However, an inde-
pendent impact on very good CNVII-LTF proved to be the tumor size ( p = 0.0000), side
( p = 0.0175), and nimodipine use ( p = 0.0349).
Conclusions: In our series, the factors related to size and side of the tumor conﬁrmed an
independent impact on CNVII-IDR and CNVIILTF. The signiﬁcance of patient positioning
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The aim of the study was to analyze the impact of various
clinical, radiological and perioperative factors that could
inﬂuence the intraoperative facial nerve (CNVII) continuity
preservation and long-term CNVII function after vestibular
schwannoma surgery.
2. Material and methods
The characteristics of the study group is presented in the
article titled ‘‘Surgery for sporadic vestibular schwannoma. Part I:
General outcome and risk of tumor recurrence.’’ The following
analyses excluded a patient who died after surgery, a patient
with no follow-up data, and a patient with a history of prior
hypoglossal-to-facial nerve anastomosis. In addition, the
analyses excluded patients previously treated at different
centers as the previous surgeries or radiosurgical procedures
had been the cause of CNVII damage before the patients were
admitted to our department. Overall, the following analyses
were conducted on a group of 212 patients. The mean
extrameatal diameter of the tumor was 30 mm. With the
retrosigmoid (210) or translabyrinthine (2) approach, gross
(210) or near-total (2) resections were carried out.
The long-term results of CNVII function were evaluated on
the last follow-up visit at least 6 months after surgery. The
House-Brackmann grades I–III were deﬁned as satisfactory
facial nerve function whereas grades IV–VI as unsatisfactory.
Grades I–II were considered as very good results.
Statistical analyses were performed to identify factors
affecting intraoperative preservation of CNVII continuity as
well as long-term CNVII function after surgery. Correlation
studies and multivariate regression analysis were performed on
factors that might possibly impact the preservation of CNVII
continuity during surgery. Factors taken into consideration
included age, gender, surgical sequence, ﬁrst tumor symptom,
symptom triggering diagnostic examinations; independent
examinations included preoperative symptoms (cerebellar
symptoms, trigeminal symptoms, CNVII paresis, headaches
and hydrocephalus), preoperative hearing according to AAO-
HNS grading scale, symptom duration, tumor size (maximum
extrameatal size, volume, tumor stage according to the Samii
grading scale), side of the tumor (left/right), tumor structure
(solid/cystic) and histological type (Antoni A, B and A + B),
internal auditory canal (IAC) widening (+/), the patient's
position during the procedure (lateral ‘‘park-bench’’/supine),
approach (RSA/TLA) and CNVII displacement pattern (anterior/
antero-medial/antero-lateral).
The analysis of long-term functional outcome included
correlations with similar factors. Additionally, three factors
were examined for possible inﬂuence on long-term CNVII
function: (1) ﬁnal EMG CNVII stimulation response, (2)postoperative complications, (3) perioperative nimodipine
administration. Postoperative complications were deﬁned in
the same manner as in the article titled: ‘‘Surgery for sporadic
vestibular schwannoma. Part II. Complications (not related to facial
and auditory nerves)’’.
For the purpose of this study, the CNVII anastomosis results
were not taken into account in the long-term functional
assessment, i.e., the CNVII function was still considered as HB
grade VI when the facial nerve continuity was not preserved
intraoperatively, even if a satisfactory result of CNVII
anastomosis was achieved.
2.1. Statistical methods
Descriptive statistics including numerical and percentage
incidence, means and standard deviations were used. The
results distributions were compared using chi-square test or
Fischer's exact test. The signiﬁcance of inter-group differences
was determined by means of Mann–Whitney's U-test or
Student's t-test for independent samples. Co-occurrence of
variables was determined using Pearson's r or Spearman's rho
correlation coefﬁcients. Dependent variable predictors were
assessed by Wald's stepwise logistic regression or enter
methods. The lowest assumed signiﬁcance level was p < 0.05.
The analyses were carried out using SPSS 18 PL software.
3. Results
3.1. Factors impacting the risk of intraoperative CNVII
disruption
3.1.1. Correlation analysis
As shown by the analysis of the ﬁrst symptoms of the disease,
an intraoperative CNVII disruption was more common when
the ﬁrst symptom was a headache or cerebellar ataxia. In these
cases, intraoperative CNVII continuity loss rates were 33% and
29%, respectively. For comparison, when the disease was ﬁrst
manifested by symptoms related to CNVIII, the continuity loss
rate was 8% ( p = 0.008, Table 1).
The analysis of symptoms leading to diagnostic examination
for vestibular schwannoma revealed no signiﬁcant differences
in CNVII preservation rates (Table 1). Examination of other
clinical factors revealed no signiﬁcant correlations between
preservation of CNVII continuity and the patient's age or gender
(Table 2). The symptom duration, cerebellar symptoms,
trigeminal nerve symptoms, hearing class according to AAO-
HNS scale, CNVII weakness or headaches as reported on
admission did not signiﬁcantly correlate with CNVII continuity
preservation. Preoperative hydrocephalus was the only preop-
erative symptom that signiﬁcantly correlated with CNVII
disruption (40% vs. 9%, p = 0.014, Table 2).
The effect of the procedure order: the facial nerve was not
preserved in 16% of the patients in the series of the ﬁrst 106
Table 1 – Correlations of the first signs of the tumor and symptoms triggering the diagnostics with CNVII anatomical
continuity preservation and the long term CNVII function. Pearson's Chi-square test.
CNVII anatomical continuity p
Not preserved Preserved
The ﬁrst symptom of the tumor
CNVIII-related symptoms 14 (8.0%) 161 (92.0%) p = 0.008
Headaches 6 (33.3%) 12 (66.7%)
Cerebellar symptoms 2 (28.6%) 5 (71.4%)
CNV-related symptoms 1 (14.3%) 6 (85.7%)
CNVII anatomical continuity p
Not preserved Preserved
The symptom triggering diagnostics
CNVIII-related symptoms 11 (8.1%) 125 (91.9%) p = 0.480
Cerebellar symptoms 6 (18.2%) 27 (81.8%)
CNV-related symptoms 2 (11.8%) 15 (88.2%)
Headaches 2 (16.7%) 10 (83.3%)
CNVII function in long term follow-up p
I–III HB IV–VI HB
The ﬁrst symptom of the tumor
CNVIII-related symptoms 141 (80.6%) 34 (19.4%) p = 0.070
Headaches 11 (61.1%) 7 (38.9%)
Cerebellar symptoms 3 (42.9%) 4 (57.1%)
CNV-related symptoms 5 (71.4%) 2 (28.6%)
CNVII function in long term follow-up p
I–III HB IV–VI HB
The symptom triggering diagnostics
CNVIII-related symptoms 109 (80.1%) 27 (19.9%) p = 0.706
Cerebellar symptoms 25 (75.8%) 8 (24.2%)
Headaches 8 (66.7%) 4 (33.3%)
CNV-related symptoms 12 (70.6% 5 (29.4%)
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( p < 0.05). No statistically signiﬁcant relationships were identi-
ﬁed between preservation of CNVII continuity and the following
tumor-related factors: tumor structure (solid vs. cyst-like), IAC
width (dilated vs. not dilated), histological type (Antoni A vs.
Antoni B vs. Antoni A + B). Facial nerve disruptions were more
common in right-sided tumors (15% vs. 6%, p = 0.047). The most
important factors were those related to tumor size. When the
tumor diameter was larger than 30 mm, the risk of CNVII
disruption was 18% as compared to 5% in case of tumors with
diameters of ≤30 mm ( p < 0.01). Likewise, the risk of CNVII
disruption in case of tumors with volumes larger than 10 cm3
was 19% as compared to 4% for smaller tumors ( p < 0.01). The
facial nerve was not preserved in 14% of patients with T4 tumors
as compared to only 3% of patients with T2–T3 tumors
( p = 0.072). The rate of intraoperative CNVII continuity loss
was 19% for surgeries performed in lateral park-bench position
and 5% for supine position with head rotated to the side. The
difference was signiﬁcant ( p < 0.01). The three most common
directions of CNVII displacement due to tumor growth, i.e.,
anterior, anteromedial and anterolateral directions, showed no
statistically signiﬁcant differences in correlations with main-
tained continuity of the CNVII. However, disruption occurred
most often when the facial nerve was dislocated in the antero-
lateral direction (13%) (Table 2). The anatomical continuity
could not be preserved in three cases where the facial nerve wasengulfed by the tumor. In one case of a giant tumor, the CNVII
could not be identiﬁed by any means.
3.1.2. Multivariate regression analysis
Multivariate regression analysis revealed that the risk of
intraoperative CNVII disruption was independently affected
by tumor volume ( p = 0.012), side of the tumor ( p = 0.028) and
patient's position during the procedure ( p = 0.016; Table 7).
Larger tumor volumes, right-sided location and lateral park-
bench position increased the risk of CNVII disruption. For
instance, the rate of CNVII disruptions in the group of patients
with right-sided tumors larger than 30 mm, undergoing surgery
in the lateral park-bench position, was as high as 35% (9/26
patients). By contrast, no CNVII disruptions were observed in
patients with a combination of the opposite factors (supine
position, left-sided tumor and size ≤30 mm, 0/44 patients).
3.2. Factors inﬂuencing the long-term postoperative CNVII
function
3.2.1. Correlation analysis for satisfactory (HB grades I–III)
CNVII function
Satisfactory CNVII function at long-term follow-up was
observed most often when the ﬁrst tumor symptoms were
related to the vestibulocochlear nerve (81%) and least often in
case of cerebellar symptoms occurring as the ﬁrst symptom
Table 2 – Correlations of various factors with CNVII continuity preservation. Pearson's Chi-square or Fisher's exact test.
Factor CNVII anatomical continuity p
Preserved Not preserved
Sex
F 116 (90%) 13 (10%) p – NS
M 73 (88%) 10 (12%)
Age
≤50 y.o. 107 (88%) 14 (12%) p – NS
>50 y.o. 82 (80%) 9 (10%)
Surgery sequence
1–106 89 (84%) 17 (16%) p < 0.05
107–112 100 (94%) 6 (6%)
Cerebellar symptoms
// 144 (92%) 13 (8%) p – NS
/+/ 45 (82%) 10 (18%)
CNV-related symptoms
// 136 (89%) 16 (11%) p – NS
/+/ 53 (88%) 7 (12%)
Headache
// 165 (91%) 17 (9%) p – NS
/+/ 24 (80%) 6 (20%)
Hydrocephalus
// 183 (91%) 19 (9%) p = 0.014
/+/ 6 (60%) 4 (40%)
Hearing acc. to AAO-HNS scale
Class A-C 48 (94%) 3 (6%) p – NS
Class D 141 (88%) 20 (12%)
CNVII weakness before surgery
HB grade I 162 (91%) 17 (9%) p – NS
HB grades II–VI 27 (82%) 6 (18%)
Symptomatic period duration
≤24 months 102 (89%) 12 (11%) p – NS
>24 months 87 (89%) 11 (11%)
Tumor stage acc. to Samii scale
T2–T3 59 (97%) 2 (6%) p = 0.072
T4 130 (86%) 21 (14%)
Maximal extrameatal tumor size
≤30 mm 112 (95%) 6 (5%) p < 0.01
>30 mm 77 (82%) 17 (18%)
Tumor volume
≤10 cm3 106 (96%) 4 (4%) p < 0.01
>10 cm3 83 (81%) 19 (19%)
Tumor structure
Solid 161 (90%) 18 (10%) p – NS
Cystic 28 (85%) 5 (15%)
Side of the tumor
Right 88 (85%) 16 (15%) p = 0.047
Left 101 (94%) 7 (6%)
Widening of IAC
// 24 (96%) 1 (4%) p – NS
/+/ 165 (88%) 22 (12%)
CNVII displacement pattern
Anterior 89 (92%) 8 (8%) p – NS
Antero-medial 60 (92%) 5 (8%)
Antero-lateral 39 (87%) 6 (13%)
Histology pattern (Antoni)
A 56 (89%) 7 (11%) p – NS
B 23 (82%) 5 (18%)
A + B 110 (91%) 11 (9%)
Patient's position during surgery
Lateral 74 (81%) 17 (19%) p = 0.003
Supine 115 (95%) 6 (5%)
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 3 6 – 4 4 39
Table 3 – Correlations for CNVII function in long-term follow-up. Independent samples t-test.
Factor CNVII function Number Mean SD p
HB grades I–III vs. IV–VI
Age HB grades I–III 164 46.4 13.2 p = 0.999
HB grades IV–VI 48 46.4 14.0
Symptomatic period duration (months) HB grades I–III 164 42.3 49.4 p = 0.970
HB grades IV–VI 48 42.0 61.7
Tumor stage HB grades I–III 164 3.6 0.6 p = 0.000
HB grades IV–VI 48 3.9 0.2
Maximal extrameatal tumor size (mm) HB grades I–III 164 28.4 10.3 p = 0.000
HB grades IV–VI 48 35.7 9.5
Tumor volume (cm3) HB grades I–III 164 11.9 12.0 p = 0.000
HB grades IV–VI 48 23.7 20.4
HB grades I–II vs. III–VI
Tumor stage HB grades I–II 141 3.5 0.64 p = 0.000
HB grades III–VI 71 4.0 0.36
Maximal extrameatal tumor size (mm) HB grades I–II 141 27.4 9.5 p = 0.000
HB grades III–VI 71 35.2 10.7
Tumor volume (cm3) HB grades I–II 141 11.0 11.4 p = 0.000
HB grades III–VI 71 21.6 18.8
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cant (Table 1). Likewise, when diagnostic examinations were
initiated due to CNVIII symptoms, a satisfactory outcome was
more common (80%) than headaches (67%, p – NS, Table 1).
Separate correlations of all symptoms presented on
admission with long-term CNVII function revealed no signiﬁ-
cant differences (Table 5). Similarly, no signiﬁcant differences
were observed in the results depending on patient's age and
gender or the duration of the symptomatic period either
(Tables 3 and 5).
After splitting the study group into 4 subgroups according
to the surgery sequence, a gradual improvement of the results
was demonstrated (Table 4). The rate of satisfactory results
was 66% in the group of the ﬁrst 53 patients as compared to
83% in the last quarter ( p = 0.044).
The rate of satisfactory results was signiﬁcantly higher in
the group of T2–T3 tumors as compared to T4 tumors (95% vs.
70%, p = 0.000). Likewise, better results were obtained for
tumor sizes of ≤3 cm (87% vs. 65%, p = 0.000) and tumor
volumes of ≤10 cm3 (87% vs. 67%, p = 0.001) (Tables 3 and 5).
Satisfactory results were more common when the tumors
were located on the left side (83% vs. 71%, p = 0.048). Other
tumor-related factors such as the tumor structure, histological
type, CNVII displacement pattern or the IAC width were of no
signiﬁcant importance for long-term CNVII function (Table 5).
Factors associated with the course of treatment, such as
patient's position during the procedure, surgical approach,
occurrence of postoperative complications and the use ofTable 4 – Correlation between surgery sequence and long-
term functional outcome. Pearson's Chi-square test;
p = 0.146.
Surgery sequence CNVII function
HB grades I–III HB grades IV–VI
Patients 1–53 35 (66%) 18 (34%)
Patients 54–106 42 (79.2%) 11 (20.8%)
Patients 107–159 43 (81.1%) 10 (18.9%)
Patients 160–212 44 (83%) 9 (17%)nimodipine in the perioperative period had no impact on the
frequency of satisfactory long-term CNVII function (Table 5).
3.2.2. Correlation analysis for very good (HB grades I–II)
CNVII function
An identical series of correlations of various factors was
analyzed for very good long-term CNVII function (HB grades I–
II). The priority role of factors associated with tumor size was
conﬁrmed (Table 3). The mean tumor size and volume in the
group of patients with very good CNVII outcome was 2.7 cm
and 11 cm3, as compared to 3.5 cm and 21 cm3, respectively, in
the group of patients with HB grades III–IV ( p = 0.000 for both
correlations).
Correlations with other factors for very good results (HB
grades I–II) revealed also several signiﬁcant differences
(Table 6). Signiﬁcantly better prognosis was observed for
patients with tumors located on the left side (HB grades I–II in
74% vs. 59%, p = 0.02). For both anterolateral and anteromedial
CNVII displacements, the rates of very good outcome were
60%. For anterior displacement, HB grades I–II outcome was
achieved in 76% ( p = 0.04). The facial nerve function was
signiﬁcantly better in patients undergoing surgery in the
supine position as compared to patients undergoing surgery in
the lateral position (HB grades I–II: 74% vs. 57%, p = 0.018). In
the group of patients receiving prophylactic nimodipine
treatment, very good results were obtained in 81% of cases.
When nimodipine was not administered, the respective rate
was 62% ( p = 0.016). In patients with preserved CNVII
continuity but with no response to ﬁnal EMG stimulation at
the brain stem, the percentage of very good results in long term
was ﬁfty percent less than in cases when the response was
obtained (41% vs. 82%, p = 0.000). The rate of very good results
in patients with postoperative complications was also signiﬁ-
cantly lower (53% vs. 71%, p = 0.019).
3.2.3. Multivariate regression analysis
Wald's regression analysis of factors correlating with the ﬁnal
outcome revealed three variables that independently inﬂu-
enced satisfactory CNVII function. These included factors
associated with tumor features, namely, the tumor size
Table 5 – Correlations of various factors with CN.VII function in long-term follow-up. Pearson's Chi-square or Fisher's exact
test.
Factor CNVII function p
HB grades I–III HB grades IV–VI
Sex
F 102 (79%) 27 (21%) p – NS
M 62 (75%) 21 (25%)
Age
≤50 y.o. 93 (77%) 28 (23%) p – NS
>50 y.o 71 (78%) 20 (22%)
Symptom duration
≤24 months 85 (75%) 29 (25%) p – NS
>24 months 79 (81%) 19 (19%)
Cerebellar symptoms
// 124 (79%) 33 (21%) p – NS
/+/ 40 (73%) 15 (27%)
CNV-related symptoms
// 121 (80%) 31 (20%) p – NS
/+/ 43 (72%) 17 (28%)
Headache
// 144 (79%) 38 (21%) p – NS
/+/ 20 (67%) 10 (33%)
Hydrocephalus
// 158 (78%) 44 (22%) p – NS
/+/ 6 (60%) 4 (40%)
Hearing acc. to AAO-HNS scale
Class A–C 45 (88%) 6 (12%) p – NS
Class D 119 (74%) 42 (26%)
CNVII before surgery
HB grade I 140 (78%) 39 (22%) p – NS
HB grades II–VI 24 (73%) 9 (27%)
Tumor stage
T2–T3 58 (95%) 3 (5%) p = 0.000
T4 106 (70%) 45 (30%)
Tumor size (max. extrameatal)
≤30 mm 103 (87%) 15 (13%) p = 0.000
>30 mm 61 (65%) 33 (35%)
Tumor volume
≤10 cm3 96 (87%) 14 (13%) p = 0.001
>10 cm3 68 (67%) 34 (33%)
Tumor structure
Solid 141 (79%) 38 (21%) p – NS
Cystic 23 (70%) 10 (30%)
Side of the tumor
Right 74 (71%) 30 (29%) p = 0.048
Left 90 (83%) 18 (17%)
IAC widening
// 22 (88%) 3 (12%) p – NS
/+/ 142 (76%) 45 (24%)
Histology pattern (Antoni)
A 52 (83%) 11 (17%) p – NS
B 17 (61%) 11 (39%)
A + B 95 (79%) 26 (21%)
CN.VII displacement pattern
Anterior 80 (82%) 17 (18%) p – NS
Antero-medial 52 (80%) 13 (20%)
Antero-lateral 31 (69%) 14 (31%)
Patient's position during surgery
Lateral 63 (69%) 28 (31%) p – NS
Supine 101 (83%) 20 (17%)
Approach
RSA 162 (77%) 48 (23%) p – NS
TLA 2 (100%) 0 (0%)
Nimodipine
// 123 (75%) 42 (25%) p – NS
/+/ 41 (87%) 6 (13%)
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Table 5 (Continued )
Factor CNVII function p
HB grades I–III HB grades IV–VI
Final EMG stimulation
Response /+/ 23 (79%) 6 (21%) p – NS
Response // 137 (90%) 15 (10%)
Postoperative complications
// 128 (80%) 31 (20%) p – NS
/+/ 36 (68%) 17 (32%)
Table 6 – Correlations of selected factors with a very good
CNVII function in long-term follow-up. Chi-square test.
Factor CNVII function p
HB grades
I–II
HB grades
III–VI
Side of the tumor
Left 80 (74%) 28 (26%) p = 0.02
Right 61 (59%) 43 (41%)
CNVII displacement pattern
Anterior 74 (76%) 23 (24%) p = 0.044
Antero-medial 39 (60%) 26 (40%)
Antero-lateral 27 (60%) 18 (40%)
Patient's position during surgery
Lateral 52 (57%) 39 (43%) p = 0.018
Supine 89 (74%) 32 (26%)
Nimodipine
// 103 (62%) 62 (38%) p = 0.016
/+/ 38 (81%) 9 (19%)
Final EMG stimulation of CNVII
Response // 12 (41%) 17 (59%) p = 0.000
Response /+/ 125 (82%) 27 (18%)
Postoperative complications
// 113 (71%) 46 (29%) p = 0.019
/+/ 28 (53%) 25 (47%)
Table 7 – Multivariate regression analysis.
Factor B BS Wald
Dependent variable: CNVII anatomical continuity preservationa
Tumor volume 0.031 0.013 6.32
Side of the tumor 1.121 0.511 4.80
Patient's position 1.251 0.518 5.82
Constant 1.686 0.423 15.90
Dependent variable: CNVII function (HB grades I–III vs. IV–VI) in long-ter
Tumor volume 0.035 0.012 8.05
Side of the tumor 0.7611 0.364 4.37
Tumor stage 1.3717 0.616 4.95
Constant 6.7061 2.364 8.04
Dependent variable: CNVII function (HB grades I–II vs. III–VI) in long-term
Tumors size 0.075 0.017 18.96
Side of the tumor 0.779 0.328 5.64
Nimodipine 0.919 0.436 4.45
Constant 1.597 0.752 4.51
a Chi-square = 20.685; p < 0.0001; Nagelkerke's R squared = 0.187. Variable
hydrocephalus.
b Chi-square = 32.784; p < 0.0001; Nagelkerke's R squared = 0.218. Variab
during surgery, histological type of tumor, postoperative complications a
c Chi-square = 33.634; p < 0.0001; Nagelkerke's R squared = 0.209. Varia
admission, tumor stage, tumor volume, patient's position during su
complications.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 3 6 – 4 442( p = 0.0045), side ( p = 0.0261) and stage ( p = 0.0366; Table 7). For
example, for right-sided, T4 tumors, larger than 3 cm, the rate
of satisfactory results was 59% (29/49) as compared to 97%
(34/35) for left-sided T2–T3 tumors.
The regression analysis for very good functional outcome
revealed an independent impact of three factors, including
tumor size ( p = 0.0000), side ( p = 0.0175) and nimodipine
administration ( p = 0.0349; Table 7). According to the obtained
results, the best prognosis was observed for patients with
small tumors (≤3 cm) located on the left side and treated with
nimodipine. In this group, the percentage of HB grades I–II
results was 94% (16/17) as compared to only 31% (12/39) in the
group characterized by a combination of the opposite features.
4. Discussion
4.1. Factors inﬂuencing the intraoperative CNVII
continuity preservation
As shown by the statistical analysis, when the ﬁrst symptoms
of the tumor included headaches or cerebellar symptoms, the
risk of facial continuity loss rates was signiﬁcantly higher p Exp (B) 95% CI for EXP (B)
5 0.012 0.969 0.946–0.993
4 0.028 3.067 1.126–8.356
5 0.016 3.494 1.265–9.648
0 0.000 5.400
m follow-upb
9 0.0045 1.036 1.011–1.061
0 0.0261 0.467 0.229–0.954
2 0.0366 3.942 1.178–13.194
7 0.0046
 follow-upc
6 0.0000 1.078 1.042–1.115
8 0.0175 0.459 0.242–0.872
2 0.0349 0.399 0.170–0.937
0 0.0337
s that did not enter the model: tumor size, cerebellar symptoms and
les that did not enter the model: tumor size, the patient's position
nd treatment with nimodipine.
bles that did not enter the model: headache, CNVII weakness at
rgery, IAC width, CNVII displacement pattern and postoperative
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 3 6 – 4 4 43reaching 33% and 29%, respectively. The same factors were
pointed out in the analysis conducted by Gerganov et al. [1].
Likewise, when hydrocephalus was presented on admission,
the risk of CNVII disruption was 40%. These variables should
be considered as collinear with the tumor size, as conﬁrmed by
further multivariate analysis. The tumor volume was the most
important independent factor inﬂuencing the CNVII continui-
ty preservation ( p = 0.012). The size of the tumor is a proven
risk factor for intraoperative CNVII interruption [2,3].
No signiﬁcant effects were observed for the tumor structure
or CNVII displacement pattern. The literature contains data
suggesting that cystic tumors, polycyclic shape and superior
CNVII displacement pattern (i.e., anteromedial displacement
according to the nomenclature used in this study), might increase
the risk of CNVII damage [1,4–6]. According to other authors,
cystic morphology of schwannoma does not worsen the CNVII
preservation rate [7,8]. Nevertheless, this might be due to a
trend toward less radical removal of cystic tumors, i.e., toward
leaving the thin tumor capsule on the facial nerve [7].
The incidence of CNVII discontinuity was signiﬁcantly
higher with surgery performed in the lateral park-bench
position as compared to supine position (19% vs. 5%, p < 0.01).
This factor was found to be of an independent impact in the
regression analysis ( p = 0.016). The lateral position was used
during the ﬁrst 91 surgeries, while supine position was used in
the last 121 patients. Therefore, the factor appears to reﬂect
the role of another variable, namely, the order of surgeries.
After the study group was divided into 2 subgroups of 106
patients each, the incidence of CNVII disruption was 16% and
6%, respectively ( p < 0.05), whereas the largest drop in the
incidence of CNVII disruption on the learning curve was
observed after 72 surgeries, from 21% to 6% ( p < 0.01).
An accidental discovery was that CNVII damage was more
common in right-sided tumors (15% vs. 6%, p = 0.047). In
addition, regression analysis revealed that this factor had an
independent effect on outcome ( p = 0.0028). Perhaps it was
because of the surgeon's handedness. In right-sided tumors,
instruments held with the right hand operate at a sharp angle
to the posterior pyramid wall and CNVII. In left-sided tumors,
this angle increases possibly facilitating the CNVII dissection
in CPA. The side of the tumor has been rarely studied. It was of
no importance in the study by Lalwani et al. [9].
4.2. Factors affecting the facial nerve function at long-term
follow-up
The following factors correlated signiﬁcantly with satisfactory
long-term CNVII function: tumor grade <T4 ( p = 0.000), tumor
size ≤3 cm ( p = 0.000), tumor volume ≤10 cm3 ( p = 0.001), left-
sided tumor location ( p = 0.048). Correlations with very good
long-term CNVII function were also identiﬁed for several other
important factors: anterior CNVII displacement ( p = 0.044),
nimodipine use ( p = 0.016), the absence of postoperative
complications ( p = 0.019) and supine position during surgery
( p = 0.018). Signiﬁcant correlations of outcome with the
patient's position during surgery are indicative rather of the
progress in the learning curve, as demonstrated above.
Regression analysis conﬁrmed the independent impact of three
factors on satisfactory long-term outcome, namely, of the tumor
volume ( p = 0.0045) and grade ( p = 0.0366) as well as side of thetumor ( p = 0.0261). An independent impact on very good long-
term outcome was identiﬁed for tumor size ( p = 0.0000) and side
( p = 0.0175), as well as nimodipine use ( p = 0.0349).
The literature underlines that the most important factors
affecting the CNVII function include the tumor size as well as
the surgeon's and site's experience [2,10–13]. In our case series,
the key role of factors related to tumor size in CNVII function
was conﬁrmed in all study periods. The role of the learning curve
will be presented separately. The possible inﬂuence of the
tumor lateralization and patient positioning were discussed
above.
Owing to routine nimodipine prophylaxis, an improvement
of long-term results was achieved. This is conﬁrmed by the
results of experimental and clinical studies conducted in recent
years [14–16]. A study in an animal model demonstrated that the
calcium channel blocker promotes faster and more effective
regeneration of damaged CNVII [14,15]. Positive results of
nimodipine treatment when initiated prophylactically on the
day before surgery or intraoperatively after neurophysiological
features of functional nerve damage detection were demon-
strated [17]. The possible mechanism of nimodipine's action
includes improvement in circulation, acceleration of axonal
growth, improved remyelination and protection against neuro-
nal degeneration. Increased inﬂux of calcium ions inside the
cells may also have an inhibitory effect on apoptosis [16,17].
Strauss et al. [16] also suggest broadening the vasoactive
treatment by administering hydroxyethyl starch solution.
Although the CNVII displacement pattern had no impact on
preservation of the nerve's continuity during the procedure, it
was correlated with long-term outcome. Anterior displace-
ment was associated with a higher percentage of very good
outcome as compared to anterolateral and anteromedial
displacements. Although this factor was not shown to be
independent, its importance has also been suggested by other
authors [4,6]. In the cited articles, superior displacement (i.e.,
anteromedial displacement according to classiﬁcation used herein)
was associated with poorer outcome.
5. Conclusions
In our series, factors related to size and side of the tumor
conﬁrmed an independent impact on CNVII intraoperative
preservation and its long-term function. The signiﬁcance of
patient positioning may reﬂect the impact of learning curve
rather than positioning itself, as only the ﬁrst 91 patients were
operated on using the lateral ‘‘park-bench’’ position. An
independent impact on long-term CNVII function was exerted
by the perioperative use of nimodipine.
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